Immune Cells
Commercialization path Dual mode driving path based on clinical translation and drug launch
Home Commercialization path

Through the dual track system of "Technology Track (National Health Commission)" and "Drug Track (National Medical Products Administration)", different pipelines are respectively registered for clinical research or IND/BLA application, ultimately achieving hospital application or industrialization.

This website uses cookies to provide you with a personalized browsing experience and analyze website traffic. By clicking 'Accept', you agree to our use of cookies.